BSC Medical - Gateway to your medical needsNew and Used Medical Equipment














Latest News



Albireo Appoints Jason G. Duncan as General Counsel and Secretary
Mon, 18 Jun 2018 15:08:40 GMT

BOSTON, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the appointment of Jason G. Duncan as Gene...
Biopharmaceuticals, Personnel
Albireo Pharma, bile acid modulator, liver disease


Elekta Unity, World's First High-Field MR-Linac, Receives CE Mark
Mon, 18 Jun 2018 15:06:16 GMT

STOCKHOLM, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- New radiation therapy system will now be implemented clinically in Europe, ushering in a transformation in precision and personalized cancer treatment Elekta (EKTA-B.ST) earlier toda...
Devices, Oncology, Radiology, Regulatory
Elekta, Elekta Unity, magnetic resonance, radiotherapy


Arcuro Medical Receives FDA Regulatory Clearance
Mon, 18 Jun 2018 15:03:40 GMT

MISGAV, Israel, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Arcuro Medical Ltd. ("Arcuro"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced today that it received regu...
Devices, Orthopaedic, FDA
Arcuro Medical, SuperBall, meniscus repair, Meniscus tear


Theranos Announces Management Transition
Mon, 18 Jun 2018 14:59:33 GMT

NEWARK, Calif., June 18, 2018 -- (Healthcare Sales & Marketing Network) -- The Board of Directors of Theranos, Inc., announced today that Elizabeth Holmes has stepped down as Chief Executive Officer and David Taylor, the Company's General Counsel, has bee...
Diagnostics, Personnel
Theranos


Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer
Mon, 18 Jun 2018 12:54:13 GMT

CARLSBAD, Calif., June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Damien McDevitt, Ph.D. has joined the company as chief business officer. In his role, Dr. McDevitt will serve as a...
Biopharmaceuticals, Personnel
Ionis Pharmaceuticals, SPINRAZA, nusinersen, TEGSEDI, inotersen, WAYLIVRA


Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Mon, 18 Jun 2018 12:48:00 GMT

Rheumatoid Arthritis Phase 4 Clinical Trial Data Recently Presented at the Annual European Congress of Rheumatology (EULAR 2018) Multiple Sclerosis Relapse Observational Registry Data Recently Presented at the 2018 Annual Meeting of the Consortium of Mu...
Biopharmaceuticals
Mallinckrodt, H.P. Acthar Gel, Rheumatoid Arthritis, Multiple Sclerosis


Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study
Mon, 18 Jun 2018 12:35:09 GMT

STOCKHOLM, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) today announced that the Board of Directors have decided to continue the discussions with the US Food and Drug Administration (FDA) to agree on the d...
Biopharmaceuticals, Oncology
Medivir, remetinostat, cutaneous T-cell lymphoma


Medtronic Receives FDA Approval for 200mm and 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
Fri, 15 Jun 2018 14:50:56 GMT

New, Extended Balloon Lengths Enable Physicians to Efficiently Treat Long SFA Lesions DUBLIN - June 15, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths of...
Devices, Interventional, FDA
Medtronic, IN.PACT Admiral, Drug-Coated Balloon, peripheral artery disease


MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress
Fri, 15 Jun 2018 12:42:17 GMT

Initiation of registration study for ME-401 in patients with relapsed or refractory follicular lymphoma expected before year-end SAN DIEGO, June 15, 2018 -- (Healthcare Sales & Marketing Network) -- MEI Pharma, Inc. (NASDAQ: MEIP) a pharmaceutical comp...
Biopharmaceuticals, Oncology
MEI Pharma, follicular lymphoma, chronic lymphocytic lymphoma


ACell, Inc. Announces Ventral Hernia Data Presented at Abdominal Wall Reconstruction Conference
Fri, 15 Jun 2018 12:37:07 GMT

COLUMBIA, Md., June 15, 2018 -- (Healthcare Sales & Marketing Network) -- ACell, Inc. today announced that promising data focused on its Gentrix Surgical Matrix family of devices for use in ventral hernia repair was presented at the recent Abdominal Wall ...
Devices, Surgery
ACell , Gentrix Surgical Matrix, MatriStem UBM, hernia repair


Source: HSMN NewsFeed